List of reimbursed drugs, is an important part of Service Packages covering the Fund of Compulsory Health Care Insurances for the population. The list of reimbursable drugs aims at improving the quality of service for all patients, particularly for people in need. In this regard, through the new list of drugs, FCHC aims at increasing the attention toward categories such as retirees and patients suffering from serious illnesses.
In compiling the list of drugs there are some scientific criteria which have been taken into consideration, by giving priority to drugs used for severe diseases; diseases of high risk for life; diseases that cause disability; diseases that risk of being spread into the society; diseases that cause much suffering as well as chronic illnesses requiring prolonged treatment.
Respiratory System - Reimbursed
Film-coated tablets - 10 mg
Syrup - 2 mg/5 ml - 150 ml
100 mg – Sugar-coated tablets
Solution for injection - (202 mg + 50.5 mg) / 10 ml (2.5%)
Solution for injection - (202 mg + 50.5 mg) / 10 ml (2.5%)
Solution for injection - (192 mg + 48 mg) / 2 ml (12%)
Syrup - 1 mg/ 5 ml
Ketofex syrup contains the active substance ketotifen fumarate, which is a medicine used for the prevention and treatment of allergic symptoms.
It is indicated in:
Note:
Ketofex syrup is not suitable for the treatment of acute asthma attacks.
A sole treatment of bronchial asthma with Ketofex syrup is not recommended.
The therapy of severe asthma should be done gradually to be successful.
The therapy should be based on continuous medical search. Doctors estimate that in the progress of the disease and treatment success a daily self-control is important.
If there is no improvement even after following a correct therapy, the doctor should reassess the therapy.
Hard capsules - 1 mg
Ketofex contains the active substance ketotifen fumarate, which is a medicine used for the prevention and treatment of allergic symptoms.
It is indicated in:
Hard capsules - 1 mg
Ketofex contains the active substance ketotifen fumarate, which is a medicine used for the prevention and treatment of allergic symptoms.
It is indicated in:
Tablets - 15 mg
Tablets – 10 mg
Syrup - 5 mg/5 ml
Sugar coated tablets - 25 mg
Promethazine is a phenothiazine derivative, which decreases or eliminates the main histamine actions by competing with histamine or reversibly blocking histamine receptors in tissues. Promethazine does not deactivate histamine, and does not prevent its secretion. H1 receptors are responsible for blood vessel dilation, increase of capillary permeability, itching and, up to an extent, for bronchial and gastrointestinal tract smooth muscle contractions. Promethazine has also antimuscarinic properties, antagonizing effects of adrenaline and serotonin and local anesthetic effects.
Prometazine 25 mg sugar-coated tablets are indicated in: